Mesenchymal stem cells: Cancer promoting effects or tumor suppression - A current overview

被引：2

作者：

Scherzad, Agmal ^{[1
]}

Taeger, Johannes ^{[1
]}

Gehrke, Thomas Eckhard ^{[1
]}

Hagen, Rudolf ^{[1
]}

Kleinsasser, Norbert ^{[1
]}

Hackenberg, Stephan ^{[1
]}

机构：

[1] Julius Maximilians Univ Wurzburg, Klin & Poliklin Hals Nasen & Ohrenkrankheiten Pla, Josef Schneider Str 11, D-97080 Wurzburg, Germany

来源：

LARYNGO-RHINO-OTOLOGIE | 2018年 / 97卷 / 10期

关键词：

mesenchymal stem cells; soluble mediators; immune suppression; neoangiogenesis; cancer stroma; STROMAL CELLS; MYOCARDIAL-INFARCTION; INTERNATIONAL-SOCIETY; PROGENITOR CELLS; IN-VITRO; GROWTH; ADHESION; THERAPY; LUNG; EXPRESSION;

D O I：

10.1055/a-0650-4673

中图分类号：

R76 [耳鼻咽喉科学];

学科分类号：

100213 ;

摘要：

The multimodal treatment of cancer deals with cancer cells as well as with the cancer surrounding stroma. This stroma contains non-malignant cells like fibroblasts, immune cells as well as mesenchymal stem cells (MSC). MSC have the ability to migrate towards cancer tissue. In the current literature the impact of MSC on cancer cells is discussed divergently. The majority of the current publications reveal an induction of cancer progression by MSC. Four main processes namely the secretion of soluble factors and cell-cell contact, the transdifferentiation of MSC into carcinoma associated fibroblasts, the improvement of neoangiogenesis and the induction of immune suppression are responsible for cancer progression. This publication gives an overview on the current literature.

引用

页码：678 / 687

页数：10

共 50 条

[41] Stem Cells and Cancer: An Overview
Kevin M. Sales
Marc C. Winslet
Alexander M. Seifalian
Stem Cell Reviews, 2007, 3 : 249 - 255
[42] Stem cells and cancer: An overview
Sales, Kevin M.
Winslet, Marc C.
Seifalian, Alexander M.
STEM CELL REVIEWS, 2007, 3 (04): : 249 - 255
[43] Immunoedited breast tumor cells demonstrate characteristics of both mesenchymal and cancer stem cells
Santistebant, Marta
Reiman, Jennifer M.
Behrens, Marshall D.
Haluska, Paul
Mukherjee, Priyabrata
Bhattacharya, Resham
Ferrone, Soldano
Kalli, Kimberly R.
Knutson, Keith L.
JOURNAL OF IMMUNOTHERAPY, 2007, 30 (08) : 889 - 890
[44] Tumor budding cells, cancer stem cells and epithelial-mesenchymal transition-
Karamitopoulou, Eva
FRONTIERS IN ONCOLOGY, 2013, 2
[45] Reciprocal modulation of mesenchymal stem cells and tumor cells promotes lung cancer metastasis
Fregni, Giulia
Quinodoz, Mathieu
Moller, Emely
Vuille, Joanna
Galland, Sabine
Fusco, Carlo
Martin, Patricia
Letovanec, Igor
Provero, Paolo
Rivolta, Carlo
Riggi, Nicolo
Stamenkovic, Ivan
EBIOMEDICINE, 2018, 29 : 128 - 145
[46] Cancer Stem Cells, Epithelial to Mesenchymal Markers, and Circulating Tumor Cells in Small Cell Lung Cancer
Pore, Milind
Meijer, Coby
de Bock, Geertruida H.
Boersma-van Ek, Wytske
Terstappen, Leon W. M. M.
Groen, Harry J. M.
Timens, Wim
Kruyt, Frank A. E.
Hiltermann, T. Jeroen N.
CLINICAL LUNG CANCER, 2016, 17 (06) : 535 - 542
[47] Interleukin-1α induces immunosuppression by mesenchymal stem cells promoting the growth of prostate cancer cells
Cheng, Jiwen
Li, Ling
Liu, Yan
Wang, Zhirou
Zhu, Xiaodong
Bai, Xianzhong
MOLECULAR MEDICINE REPORTS, 2012, 6 (05) : 955 - 960
[48] Suppression of adipogenesis in mouse mesenchymal stem cells by imipramine
Li, Haifang
TISSUE & CELL, 2012, 44 (02): : 132 - 136
[49] Tumor suppression effects of myoepithelial cells on mice breast cancer
Farhanji, Baharak
Latifpour, Mostafa
Alizadeh, Ali Mohammad
Khodayari, Hamid
Khodayari, Saeed
Khaniki, Mahmood
Ghasempour, Sarieh
EUROPEAN JOURNAL OF PHARMACOLOGY, 2015, 765 : 171 - 178
[50] Tumor-infiltrating mesenchymal stem cells: Drivers of the immunosuppressive tumor microenvironment in prostate cancer?
Krueger, Timothy E.
Thorek, Daniel L. J.
Meeker, Alan K.
Isaacs, John T.
Brennen, W. Nathaniel
PROSTATE, 2019, 79 (03): : 320 - 330

← 1 2 3 4 5 →